Normal Levels Of Vitamin D Is Associated With Improved Treatment Of Some Leukemia Patients – Part 2 of 3
And “This watch-and-wait closer is difficult for patients because they feel there is nothing they can do to help themselves,” Shanafelt said in a Mayo news release. “It appears vitamin D levels may be a modifiable hazard factor for leukemia progression. It is simple for patients to have their vitamin D levels checked by their physicians with a blood test. And if they are deficient, vitamin D supplements are everywhere available and have minimal side effects”.
This study of 390 CLL patients found that 30 percent of them had insufficient vitamin D levels (less than 25 nanograms per milliliter) at the control of cancer diagnosis. After a median follow-up of three years, patients with insufficient vitamin D levels were 66 percent more likely to have disease progression and to require chemotherapy. They also had a twofold increased imperil of death, compared to those with adequate vitamin D levels.